PMDA implemented an organizational reconstructing of Office of International Programs on April 1st, 2020, aiming of strengthening of cooperative relationship with Asian countries.
Last year, Japanese government published “Grand Design for Asian Pharmaceutical and Medical Device Regulatory Harmonization“. The purpose of this harmonization is to realize “Universal Health Coverage (UCH)” in the international field. To realize UCH, Japan concluded that it is essential improve basic services to prevent infections/non-infectious diseases and improve treatment of diseases. Because pharmaceuticals and medical devices, including innovative technologies, to utilize these products are not sufficient in every Asian country, Japan developed the Grand Design for Asian Pharmaceutical and Medical Device Regulatory Harmonization to take initiatives of realizing of people’s wellbeing in Asian region.
In this April, PMDA newly established Division of Asia I and Division of Asia II in the Office of International Programs, appointed International Coordination Officers and other dedicated staff from priority country/area. The Division of Asia I handles“Non-ASEAN country/region”, and Division of Asia II handleson “ASEAN country/region”.
| RECOMMEND READING |
|
- JAPAN: MHLW Announces Single - Use Parts of Air Ventilators Are Allowed to Be Reused - JAPAN: PMDA Takes Further Steps to Speed up Clinical Development of COVID-19 Product
|
References:
Grand Design for Asian Pharmaceutical and Medical Device Regulatory Harmonization